IBEX 35
11.322,00 -16,20 (-0,14%) Euro Stoxx 50
4.983,67 +1,49 (+0,03%) Dólar/Euro
1,0854 +0,0019 (+0,17%) Petróleo Brent
81,58 -0,28 (-0,34%) Oro
2.347,70 -18,80 (-0,79%) Bitcoin EUR
62.281,76 -525,46 (-0,84%)
Sinopharm Group Co. Ltd. (X2S.F)
Sinopharm Group Co. Ltd.
Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn
Sector(es): Healthcare
Sector: Medical Distribution
Empleados a tiempo completo: 115.959
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Qingming Yu | Executive Chairman of the Board | 875,2k | N/A | 1964 |
| Mr. Yong Liu | President & Executive Director | 845,19k | N/A | 1969 |
| Ms. Xiaojuan Li | Chief Financial Officer | N/A | N/A | 1976 |
| Mr. Yijian Wu | Secretary to the Board, Company Secretary & Authorised Representative | N/A | N/A | 1970 |
Descripción
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Gobierno corporativo
El ISS Governance QualityScore de Sinopharm Group Co. Ltd., a día 29 de mayo de 2024, es 7. Las puntuaciones base son Auditoría: 6; Tablero: 9; Derechos de los accionistas: 9; Compensación: 2.
